In the MASLD mouse model of disordered lipid metabolism, the decline of CD4+ T cells in the liver can be related to the exacerbation of their apoptosis by high levels of fatty acids, whereas by inhibiting ROS, it is possible to restore the number of CD4+ T cells and to delay the tendency to transform into HCC (66). The gene discussed is CD4; the disease is hepatocellular carcinoma.